Trial Profile
Effect of dasatinib or nilotinib in patients with Chronic Myeloid Leukemia and previously receiving imatinib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2015
Price :
$35
*
At a glance
- Drugs Nilotinib (Primary) ; Dasatinib
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 12 May 2015 New trial record